glp 1 hfpef Hydrogen Sulfide Deficiency and Therapeutic Targeting in Cardiometabolic HFpEF: Evidence for Synergistic Benefit With GLP-1/Glucagon Agonism GLP-1 Drugs Reduce Risk of

Given the progressive decline in maternal blood GLP-1 concentration during pregnancy, the utilization of GLP-1RA serves as a justifiable approach to delineate the regulatory effect of GLP-1 on fetal growth

What the Research Shows Recent research on semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has revealed concerning trends about body composition changes: A 2023 analysis of STEP trial data found that approximately 39% of weight lost on semaglutide was lean body mass 1 Research on tirzepatide showed similar patterns, with 30-40% of total weight loss coming from lean tissue 2 Comparative studies indicate GLP-1 users may lose more muscle than people losing weight through diet and exercise alone 3 For context: if you lose 50 pounds on a GLP-1 medication, 15-20 pounds might be muscle mass

These group B receptors include GPCRs that selectively bind secretin, glucagon, glucose-dependent insulinotropic peptide (GIP), vasoactive intestinal peptide (VIP), and pituitary adenylyl cyclase-activating peptide (PACAP)

Of course, obesity can also hinder older adults health and quality of life, but Batsis says theres a fine balance to strike when it comes to weight loss